BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1708926)

  • 1. Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro.
    Bilzer T; Stavrou D; Dahme E; Keiditsch E; Bürrig KF; Anzil AP; Wechsler W
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):281-93. PubMed ID: 1708926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen variation in a human glioblastoma: from the primary tumor to the second recurrence, permanent cell line and xenotransplantation tumors.
    Bilzer T; Stavrou D; Wechsler W; Wöhler B; Keiditsch E
    Anticancer Res; 1991; 11(2):547-53. PubMed ID: 2064311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme.
    Bocchini V; Casalone R; Collini P; Rebel G; Lo Curto F
    Cell Tissue Res; 1991 Jul; 265(1):73-81. PubMed ID: 1655272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of glial cell differentiation by exposure to lead and cadmium.
    Stark M; Wolff JE; Korbmacher A
    Neurotoxicol Teratol; 1992; 14(4):247-52. PubMed ID: 1522829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique model system for tumor progression in GBM comprising two developed human neuro-epithelial cell lines with differential transforming potential and coexpressing neuronal and glial markers.
    Shiras A; Bhosale A; Shepal V; Shukla R; Baburao VS; Prabhakara K; Shastry P
    Neoplasia; 2003; 5(6):520-32. PubMed ID: 14965445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor.
    Halfter H; Kremerskothen J; Weber J; Hacker-Klom U; Barnekow A; Ringelstein EB; Stögbauer F
    J Neurooncol; 1998 Aug; 39(1):1-18. PubMed ID: 9760066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA content and chromosomal composition of malignant human gliomas.
    Bigner SH; Bjerkvig R; Laerum OD
    Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological heterogeneity and phenotype modifications during long term in vitro cultures of six new human glioblastoma cell lines.
    Dipasquale B; Colombatti M; Tridente G
    Tumori; 1990 Apr; 76(2):172-8. PubMed ID: 2330609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic staining patterns of human glioma cultures: primary cultures, long-term cultures and cell lines.
    Westphal M; Nausch H; Herrmann HD
    J Neurocytol; 1990 Aug; 19(4):466-77. PubMed ID: 2243242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses.
    Kruse CA; Mitchell DH; Kleinschmidt-DeMasters BK; Franklin WA; Morse HG; Spector EB; Lillehei KO
    In Vitro Cell Dev Biol; 1992; 28A(9-10):609-14. PubMed ID: 1331021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a new cell line derived from a human gliosarcoma.
    Iwasaki K; Kikuchi H; Miyatake S; Kondo S; Oda Y
    Neurosurgery; 1992 Feb; 30(2):228-35. PubMed ID: 1545891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and karyotypic characterization of a new cell line derived from human gliosarcoma.
    Westphal M; Haensel M; Mueller D; Laas R; Kunzmann R; Rohde E; Koenig A; Hoelzel F; Herrmann HD
    Cancer Res; 1988 Feb; 48(3):731-40. PubMed ID: 3275500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of the two glioma cell lines: YH and AM.
    Izumi I; Mineura K; Watanabe K; Kowada M
    Hum Cell; 1994 Jun; 7(2):101-5. PubMed ID: 7947440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM; Kong FM; Bigner DD; Hale LP
    Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of transferrin receptor expression on glioma cell lines by using magnetic microspheres.
    Wen DY; Hall WA; Fodstad O
    Neurosurgery; 1993 Nov; 33(5):878-81. PubMed ID: 8264887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
    Fazekas I; Kerekes E; Hegedús B; Nyáry I
    Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
    Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiocentric glioma: report of clinico-pathologic and genetic findings in 8 cases.
    Preusser M; Hoischen A; Novak K; Czech T; Prayer D; Hainfellner JA; Baumgartner C; Woermann FG; Tuxhorn IE; Pannek HW; Bergmann M; Radlwimmer B; Villagrán R; Weber RG; Hans VH
    Am J Surg Pathol; 2007 Nov; 31(11):1709-18. PubMed ID: 18059228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Karyotype analyses of 20 human glioma cell lines.
    Westphal M; Hänsel M; Hamel W; Kunzmann R; Hölzel F
    Acta Neurochir (Wien); 1994; 126(1):17-26. PubMed ID: 8154317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.